CRJDM (CRJDM) Token Sayfası

The core purpose of CRJDM is to accelerate diagnostic and therapeutic discovery in Juvenile Dermatomyositis by transforming parent-collected, at-home blood samples into ethically governed, high-resolution immune datasets powered by O’Ryan Health’s Artemis Platform and coordinated through a coin-2-company model. The study is IRB-approved, and families have successfully collected over one hundred samples from their children diagnosed with JDM and Healthy siblings.

CRJDM funding will empower families to continue collecting blood samples at home for JDM research, to build the first decentralized “immune atlas” for Juvenile Dermatomyositis, and accelerating discovery of early diagnostics and new treatments.